Westfield Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-210,226
Closed -$15.7M 280
2018
Q4
$15.7M Sell
210,226
-131,100
-38% -$10.8M 0.13% 174
2018
Q3
$31.4M Sell
341,326
-186,115
-35% -$17.7M 0.22% 151
2018
Q2
$51.9M Buy
527,441
+42,681
+9% +$4.77M 0.39% 88
2018
Q1
$54M Buy
484,760
+167,287
+53% +$18.7M 0.42% 86
2017
Q4
$32.7M Buy
317,473
+196,643
+163% +$19.6M 0.25% 150
2017
Q3
$11.4M Buy
+120,830
New +$9.54M 0.09% 200

Other funds holding CMD

Westfield Capital Management's CMD Position: Q1 2019 in Review

Westfield Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 210,226 shares — an estimated $15.7M sold.

Westfield Capital Management first reported a position in CMD in Q3 2017 and held it in 6 quarters. The position peaked at $54M in Q1 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • Westfield Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Westfield Capital Management sold 210,226 Cantel Medical Corporation shares in Q1 2019, an estimated $15.7M.
  • Westfield Capital Management first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 6 quarters.
  • Westfield Capital Management's Cantel Medical Corporation position peaked at $54M in Q1 2018.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Westfield Capital Management's 13F filing for Q1 2019, filed 14 May 2019.